---
layout: post
title: "Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:58:00 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-02446
original_published: 2022-02-07 00:00:00 +0000
significance: 8.00
---

# Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** February 07, 2022 00:00 UTC
**Document Number:** 2022-02446

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs." This draft guidance provides recommendations to industry on formal meetings between FDA and sponsors or requestors of over-the-counter (OTC) monograph drugs.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/02/07/2022-02446/formal-meetings-between-the-food-and-drug-administration-and-sponsors-or-requestors-of)
- API: https://www.federalregister.gov/api/v1/documents/2022-02446

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
